6505--Pregabalin Capsules
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), National Acquisition Center, has awarded a contract for Pregabalin Capsules to SCIEGEN PHARMACEUTICALS INC for $14,500,887.25. This award, under Solicitation Number 36E79725R0055, is for an unrestricted procurement to ensure an uninterrupted supply of this pharmaceutical.
Scope of Work
The contract covers the provision of Pregabalin Capsules in various dosages and bottle sizes. These supplies are intended for the VA (including CMOPs and State Veterans Homes), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Centers (FHCC). Key requirements for the product included a unique NDC number and specific unit of use packaging with a safety-cap and minimum bottle volume.
Contract & Timeline
- Awardee: SCIEGEN PHARMACEUTICALS INC (UEI: WH8BR7NRXLC5)
- Award Amount: $14,500,887.25
- Award Number: 36E79726D0006
- Award Date: December 1, 2025
- Contract Period: One year with four one-year pre-priced option periods (as per original solicitation).
- Set-Aside: Unrestricted
- Product Service Code: 6505 (Drugs And Biologicals)
- NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing)
Evaluation
The original pre-solicitation indicated that all responsible sources were eligible to submit an offer for this procurement.
Additional Notes
This is an award notice published on February 11, 2026, detailing the outcome of the solicitation. The contract items will be distributed via the VA’s and DoD’s Pharmaceutical Prime Vendor Programs. The point of contact for the original solicitation was Youlanda Duggar (Youlanda.Duggar@va.gov).